Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

ABT-384

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
  • G. An
  • Journal of clinical pharmacology
  • 2019
  • Corpus ID: 208609332
Target‐mediated drug disposition (TMDD) is a term to describe a nonlinear pharmacokinetic (PK) phenomenon that is caused by high… Expand
Review
2017
Review
2017
  • G. An
  • Journal of clinical pharmacology
  • 2017
  • Corpus ID: 29569379
Nonlinearities are commonplace in pharmacokinetics, and 1 special source is the saturable binding of the drug to a high‐affinity… Expand
2016
2016
Resume La 11β-hydroxysteroide deshydrogenase de type 1 (11βHSD1) est une enzyme intervenant dans la transformation tissulaire de… Expand
Review
2015
Review
2015
Nonlinearities are frequently encountered in pharmacokinetics, and they can occur when 1 or more processes of absorption… Expand
2014
2014
In this study we assessed increased cortisol in Alzheimer's disease (AD) patients. The selective 11‐β‐hydroxysteroid… Expand
2014
2014
ABT‐384 is a potent and selective inhibitor of 11β‐hydroxysteroid dehydrogenase type 1 (HSD‐1). The pharmacokinetics of ABT‐384… Expand
2013
2013
ABT‐384 is a potent and selective inhibitor of 11β‐hydroxysteroid dehydrogenase type 1 (HSD‐1), the enzyme that regenerates… Expand
2013
2013
ABT-384 is a potent, selective inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 (HSD-1). One milligram of ABT-384 daily… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
ABT-384 [1-piperazineacetamide, N-[5-(aminocarbonyl) tricyclo[3.3.1.13,7]dec-2-yl]-α,α-dimethyl-4-[5-(trifluoromethyl)-2… Expand
  • figure 2
  • figure 3
  • table 1
  • figure 4
  • table 2